
CAC2 Childhood Cancer Community News Digest (April 17-23)
Assorted News from the Last Week: Children with acute lymphoblastic leukemia (ALL) who live in extreme poverty and were undergoing maintenance therapy faced an almost

Assorted News from the Last Week: Children with acute lymphoblastic leukemia (ALL) who live in extreme poverty and were undergoing maintenance therapy faced an almost

Assorted News from the Last Week: Cancer researchers continue to make progress in developing tests using liquid biopsies for pediatric solid tumors that could complement

Assorted News from the Last Week: From the Journal of Clinical Oncology: “An optimized, agreed approach to the design and evaluation of early-phase pediatric combination trials

Assorted News from the Last Week: Melissa Jackson joins the Coalition Against Childhood Cancer as its new Executive Director. NCI Director Monica Bertagnolli announced the

By CAC2 Chair Amy Godkin (ASK Foundation) We are thrilled to share the good news that Melissa Jackson is joining CAC2 as our new Executive

Assorted News from the Last Week: Findings from a cohort study published in JAMA Network Open found that survivors of childhood cancer who lived in

Assorted News from the Last Week: Results from a new study show that giving a drug called dexrazoxane (Zinecard) before each dose of doxorubicin substantially

Assorted News from the Last Week: This year’s Grand Challenge includes a focus on pediatric solid tumors! One of the nine announced challenges seeks to

We learned more about the Alliance for Childhood Cancer Action Days, which is returning to Washington, D.C., this year for the first time since 2019.

Assorted News from the Last Week: In March last year, the CCDI Molecular Characterization Initiative (MCI) launched. Since then, it has opened enrollment to children,